These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3876901)

  • 1. Subclinical manifestations of autoimmune rheumatic diseases in primary Raynaud's phenomenon.
    Tzioufas AG; Dalavanga YA; Constantopoulos SH; Tsianos EB; Papadimitriou C; Moutsopoulos HM
    Clin Exp Rheumatol; 1985; 3(3):243-7. PubMed ID: 3876901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of peripheral cold exposure on oesophageal motility in patients with autoimmune rheumatic diseases and Raynaud's phenomenon.
    Tsianos EV; Berecos C; Stavropoulos E; Kazazis E; Danielides IC; Drosos AA
    Clin Rheumatol; 1991 Sep; 10(3):311-5. PubMed ID: 1790643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Esophageal motor changes in patients with Raynaud's phenomenon and suspected scleroderma. Electromanometric and serologic evaluations].
    Benevento A; Barcellini W; Maestri L; Riva R; Sabbadini MG; Veralli E
    Minerva Med; 1984 Sep; 75(37):2111-8. PubMed ID: 6483266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Esophageal motility in Raynaud's disease, systemic scleroderma and presclerodermal Raynaud's syndrome].
    Hostein J; Bost R; Carpentier P; Franco A; Fournet J
    Gastroenterol Clin Biol; 1985 Feb; 9(2):130-5. PubMed ID: 3979734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic involvement and immunologic findings in patients presenting with Raynaud's phenomenon.
    Kallenberg CG; Wouda AA; The TH
    Am J Med; 1980 Nov; 69(5):675-80. PubMed ID: 6969028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raynaud's phenomenon in systemic lupus erythematosus.
    Lavras Costallat LT; Valente Coimbra AM
    Rev Rhum Engl Ed; 1995 May; 62(5):349-53. PubMed ID: 7655867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Raynaud's phenomenon - first sign of malignancy: case report].
    Sutić A; Gračanin G; Morović-Vergles J
    Acta Med Croatica; 2014 Jun; 68(3):295-8. PubMed ID: 26016221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Esophageal hypomotility in primary and secondary Raynaud's phenomenon: comparison of esophageal scintigraphy with manometry.
    Limburg AJ; Beekhuis H; Smit AJ; Kallenberg CG; Piers DA; Kleibeuker JH
    J Nucl Med; 1995 Mar; 36(3):451-5. PubMed ID: 7884508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic abnormalities in idiopathic Raynaud's phenomenon.
    Moutsopoulos HM; Constantopoulos S; Gerber LH; Lawley TJ
    Clin Exp Rheumatol; 1983; 1(1):45-8. PubMed ID: 6681124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical significance of Raynaud's syndrome.
    Porter JM; Bardana EJ; Baur GM; Wesche DH; Andrasch RH; Rösch J
    Surgery; 1976 Dec; 80(6):756-64. PubMed ID: 1006524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnosis and treatment of Raynaud's phenomenon.
    Porter JM; Snider RL; Bardana EJ; Rösch J; Eidemiller LR
    Surgery; 1975 Jan; 77(1):11-23. PubMed ID: 1078555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Q: When do Raynaud symptoms merit a workup for autoimmune rheumatic disease?
    Chatterjee S
    Cleve Clin J Med; 2013 Jan; 80(1):22-5. PubMed ID: 23288940
    [No Abstract]   [Full Text] [Related]  

  • 13. [Raynaud's phenomenon. Practical considerations on the forms secondary to immunomediated systemic diseases].
    Marcolongo R; Corà F; Laveder F; Cavallo M; Busato A; Rigoli AM
    Minerva Med; 1997; 88(7-8):307-10. PubMed ID: 9304074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Esophageal motility studies in patients with Raynaud's phenomenon.
    Fitzgerald OM; Bongiovanni G; Hess EV; Merhar G; Fernandez-Ulloa M; Spencer-Green G
    J Rheumatol; 1987 Apr; 14(2):273-7. PubMed ID: 3598996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raynaud's phenomenon in primary Sjögren's syndrome.
    Skopouli FN; Talal A; Galanopoulou V; Tsampoulas CG; Drosos AA; Moutsopoulos HM
    J Rheumatol; 1990 May; 17(5):618-20. PubMed ID: 2359071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic autoimmune disease and Raynaud's phenomenon: a common, immunologically mediated, vascular basis?
    Kallenberg CG; Wouda AA; The TH
    Neth J Med; 1984; 27(9):322-6. PubMed ID: 6334812
    [No Abstract]   [Full Text] [Related]  

  • 17. [Idiopathic and secondary Raynaud's phenomenon. A comparative psychosomatic approach].
    Bayle O; Consoli SM; Baudin M; Vayssairat M; Fiessinger JN; Housset E
    Presse Med; 1990 Apr; 19(16):741-5. PubMed ID: 2140158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raynaud's phenomenon.
    Lally EV
    Curr Opin Rheumatol; 1992 Dec; 4(6):825-36. PubMed ID: 1457277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Necrotizing sialometaplasia in a patient with Buerger's disease and Raynaud's phenomenon.
    Rye LA; Calhoun NR; Redman RS
    Oral Surg Oral Med Oral Pathol; 1980 Mar; 49(3):233-6. PubMed ID: 6928308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nailfold capillaroscopy in juvenile rheumatic diseases: known measures, patterns and indications.
    Gerhold K; Becker MO
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-183-8. PubMed ID: 24960119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.